Valuation: Vivos Therapeutics, Inc.

Market Cap 5.69M 4.97M 4.6M 4.25M 8M 547M 8.15M 54.84M 21.52M 268M 21.38M 20.91M 922M P/E 2026 *
-0.29x
P/E 2027 * -0.52x
Enterprise Value 5.69M 4.97M 4.6M 4.25M 8M 547M 8.15M 54.84M 21.52M 268M 21.38M 20.91M 922M EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.17x
Free-Float
74.28%
Yield 2026 *
-
Yield 2027 * -
1 day-2.36%
1 week-14.47%
Current month-9.86%
1 month-28.37%
3 months-69.65%
6 months-80.40%
Current year-79.82%
1 week 0.4
Extreme 0.4041
0.48
1 month 0.38
Extreme 0.383
0.58
Current year 0.38
Extreme 0.383
2.69
1 year 0.38
Extreme 0.383
6.73
3 years 0.38
Extreme 0.383
48.79
5 years 0.38
Extreme 0.383
177.25
10 years 0.38
Extreme 0.383
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap.
02-04Other

Director

3,997 0.0424%
26/11/24Other

Chief Executive Officer

315,421 6.6191%
26/11/24Other

Chief Financial Officer

149,533 3.1380%
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-14.47%-94.11%-94.82% 5.83M
-0.84%-0.64%+32.15%+0.42% 12.54B
-1.62%+0.39%+9.80%+11.75% 5.91B
-3.38%-4.27%+53.67%+27.74% 5.85B
-6.58%-2.15% - - 4.52B
-1.55%+10.23%-30.22%+15.83% 4.31B
+2.24%+3.50%-22.41%-24.23% 3.87B
+0.47%+0.31%+3.05%+251.43% 1.87B
-3.36%-12.25%-10.73%-61.07% 1.86B
+0.66%+1.00%+54.43%-3.81% 1.54B
Average -1.62%-1.40%-0.48%+13.69% 4.23B
Weighted average by Cap. -1.69%+0.21%+16.60%+14.85%

Financials

2026 *2027 *
Net sales 24.06M 21.02M 19.43M 17.95M 33.81M 2.31B 34.42M 232M 90.93M 1.13B 90.36M 88.36M 3.9B 34.09M 29.79M 27.54M 25.44M 47.91M 3.27B 48.78M 328M 129M 1.6B 128M 125M 5.52B
Net income -23.82M -20.81M -19.24M -17.78M -33.47M -2.29B -34.08M -229M -90.02M -1.12B -89.46M -87.48M -3.86B -13.78M -12.05M -11.14M -10.29M -19.37M -1.32B -19.73M -133M -52.1M -648M -51.78M -50.63M -2.23B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
14/07/26 $0.4097 -2.36% 242,440
13/07/26 $0.4196 -2.87% 173,639
10/07/26 $0.4320 -7.22% 173,885
09/07/26 $0.4656 -3.00% 88,210
08/07/26 $0.4800 +0.21% 139,284
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4097USD
Average target price
2.117USD
Spread / Average Target
+416.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock